Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report
Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report
Abstract
Summary
Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Gilead Sciences, Inc. (Gilead or 'the company') is a biopharmaceutical company. The company develops and markets medicines for HIV/AIDS, liver diseases, oncology, inflammation and serious cardiovascular and respiratory conditions. The company offers its products under various brands, including AmBisome, Atripla, Cayston, Complera/Eviplera, Emtriva, Genvoya, Hepsera, Harvoni, Letairis, Lexiscan /Rapiscan, Macugen, Ranexa, Stribild, Tamiflu, Truvada, Tybost, Viread, Vosevi, Zydelig and Sovaldi. Gilead markets its products through commercial teams and in conjunction with third-party distributors and corporate partners. The company sells and distributes most of its products in the US through the wholesale channel. It has business presence in the US, Europe and other countries. The company is headquartered in Foster City, California, the US.
Scope
- Detailed information on Gilead Sciences, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Gilead Sciences, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Gilead Sciences, Inc. including a breakdown and examination of key business segments
- Intelligence on Gilead Sciences, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Gilead Sciences, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Gilead Sciences, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Gilead Sciences, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Gilead Sciences, Inc.'s business structure, strategy and prospects.
Content
Table of Contents
Company Snapshot
Gilead Sciences, Inc.: Company Overview
Gilead Sciences, Inc.: Overview and Key Facts
Gilead Sciences, Inc.: Overview
Gilead Sciences, Inc.: Key Facts
Gilead Sciences, Inc.: Key Employees
Gilead Sciences, Inc.: Key Employee Biographies
Gilead Sciences, Inc.: Major Products and Services
Gilead Sciences, Inc.: Company History
Gilead Sciences, Inc.: Management Statement
Gilead Sciences, Inc.: Locations and Subsidiaries
Gilead Sciences, Inc.: Key Competitors
Gilead Sciences, Inc.: Company Analysis
Gilead Sciences, Inc.: Business Description
Gilead Sciences, Inc.: SWOT Analysis
Gilead Sciences, Inc.: SWOT Overview
Gilead Sciences, Inc.: Strengths
Gilead Sciences, Inc.: Weaknesses
Gilead Sciences, Inc.: Opportunities
Gilead Sciences, Inc.: Threats
Gilead Sciences, Inc.: Corporate Financial Deals Activity
Gilead Sciences, Inc.: Financial Deals Overview
Gilead Sciences, Inc.: Targets and Partners
Gilead Sciences, Inc.: Top Deals 2018 - 2022YTD*
Gilead Sciences, Inc.: Advisors
Gilead Sciences, Inc.: Top Legal Advisors
Gilead Sciences, Inc.: Top Financial Advisors
Gilead Sciences, Inc.: Mergers and Acquisitions
Gilead Sciences, Inc.: Corporate Venturing
Gilead Sciences, Inc.: Capital Raising
Gilead Sciences, Inc.: Partnership
Gilead Sciences, Inc.: Divestments
Gilead Sciences, Inc.: Recent Developments
Gilead Sciences, Inc.: News and Events Summary
Gilead Sciences, Inc.: Corporate Governance
Gilead Sciences, Inc.: Financial Deals
Gilead Sciences, Inc.: Financial Performance
Gilead Sciences, Inc.: Market Developments
Gilead Sciences, Inc.: Research & Development
Gilead Sciences, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List Of Tables
Table 1: Gilead Sciences, Inc.: Key Facts
Table 2: Gilead Sciences, Inc.: Key Employees
Table 3: Gilead Sciences, Inc.: Company History
Table 4: Gilead Sciences, Inc.: Locations and Subsidiaries
Table 5: Gilead Sciences, Inc.: Key Competitors
Table 6: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Gilead Sciences, Inc.: M&A Activity by Geography (TTM*)
Table 8: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 9: Gilead Sciences, Inc.: M&A Average Deal Size - Value (US$m)
Table 10: Gilead Sciences, Inc.: Targets and Partners
Table 11: Gilead Sciences, Inc.: Top Deals 2018 - 2022YTD*
Table 12: Gilead Sciences, Inc.: Legal Advisor Ranking by Value (US$m)
Table 13: Gilead Sciences, Inc.: Financial Advisor Ranking by Value (US$m)
Table 14: Gilead Sciences, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Table 15: Gilead Sciences, Inc.: M&A Activity by Geography (2018 - YTD*2022)
Table 16: Gilead Sciences, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Table 17: Gilead Sciences, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
Table 18: Gilead Sciences, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Table 19: Gilead Sciences, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Table 20: Gilead Sciences, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 21: Gilead Sciences, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 22: Gilead Sciences, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
Table 23: Gilead Sciences, Inc.: News and Events Summary
Table 24: Gilead Sciences, Inc.: Corporate Governance
Table 25: Gilead Sciences, Inc.: Financial Deals
Table 26: Gilead Sciences, Inc.: Financial Performance
Table 27: Gilead Sciences, Inc.: Market Developments
Table 28: Gilead Sciences, Inc.: Research & Development
Table 29: Gilead Sciences, Inc.: Strategy and Operations
List Of Figures
Figure 1: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Gilead Sciences, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 4: Gilead Sciences, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Gilead Sciences, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Figure 6: Gilead Sciences, Inc.: M&A Activity by Geography (2018 - YTD*2022)
Figure 7: Gilead Sciences, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Figure 8: Gilead Sciences, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
Figure 9: Gilead Sciences, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Figure 10: Gilead Sciences, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Figure 11: Gilead Sciences, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Figure 12: Gilead Sciences, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
Figure 13: Gilead Sciences, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
Summary
Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Gilead Sciences, Inc. (Gilead or 'the company') is a biopharmaceutical company. The company develops and markets medicines for HIV/AIDS, liver diseases, oncology, inflammation and serious cardiovascular and respiratory conditions. The company offers its products under various brands, including AmBisome, Atripla, Cayston, Complera/Eviplera, Emtriva, Genvoya, Hepsera, Harvoni, Letairis, Lexiscan /Rapiscan, Macugen, Ranexa, Stribild, Tamiflu, Truvada, Tybost, Viread, Vosevi, Zydelig and Sovaldi. Gilead markets its products through commercial teams and in conjunction with third-party distributors and corporate partners. The company sells and distributes most of its products in the US through the wholesale channel. It has business presence in the US, Europe and other countries. The company is headquartered in Foster City, California, the US.
Scope
- Detailed information on Gilead Sciences, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Gilead Sciences, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Gilead Sciences, Inc. including a breakdown and examination of key business segments
- Intelligence on Gilead Sciences, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Gilead Sciences, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Gilead Sciences, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Gilead Sciences, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Gilead Sciences, Inc.'s business structure, strategy and prospects.
Table of Contents
Company Snapshot
Gilead Sciences, Inc.: Company Overview
Gilead Sciences, Inc.: Overview and Key Facts
Gilead Sciences, Inc.: Overview
Gilead Sciences, Inc.: Key Facts
Gilead Sciences, Inc.: Key Employees
Gilead Sciences, Inc.: Key Employee Biographies
Gilead Sciences, Inc.: Major Products and Services
Gilead Sciences, Inc.: Company History
Gilead Sciences, Inc.: Management Statement
Gilead Sciences, Inc.: Locations and Subsidiaries
Gilead Sciences, Inc.: Key Competitors
Gilead Sciences, Inc.: Company Analysis
Gilead Sciences, Inc.: Business Description
Gilead Sciences, Inc.: SWOT Analysis
Gilead Sciences, Inc.: SWOT Overview
Gilead Sciences, Inc.: Strengths
Gilead Sciences, Inc.: Weaknesses
Gilead Sciences, Inc.: Opportunities
Gilead Sciences, Inc.: Threats
Gilead Sciences, Inc.: Corporate Financial Deals Activity
Gilead Sciences, Inc.: Financial Deals Overview
Gilead Sciences, Inc.: Targets and Partners
Gilead Sciences, Inc.: Top Deals 2018 - 2022YTD*
Gilead Sciences, Inc.: Advisors
Gilead Sciences, Inc.: Top Legal Advisors
Gilead Sciences, Inc.: Top Financial Advisors
Gilead Sciences, Inc.: Mergers and Acquisitions
Gilead Sciences, Inc.: Corporate Venturing
Gilead Sciences, Inc.: Capital Raising
Gilead Sciences, Inc.: Partnership
Gilead Sciences, Inc.: Divestments
Gilead Sciences, Inc.: Recent Developments
Gilead Sciences, Inc.: News and Events Summary
Gilead Sciences, Inc.: Corporate Governance
Gilead Sciences, Inc.: Financial Deals
Gilead Sciences, Inc.: Financial Performance
Gilead Sciences, Inc.: Market Developments
Gilead Sciences, Inc.: Research & Development
Gilead Sciences, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List Of Tables
Table 1: Gilead Sciences, Inc.: Key Facts
Table 2: Gilead Sciences, Inc.: Key Employees
Table 3: Gilead Sciences, Inc.: Company History
Table 4: Gilead Sciences, Inc.: Locations and Subsidiaries
Table 5: Gilead Sciences, Inc.: Key Competitors
Table 6: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Gilead Sciences, Inc.: M&A Activity by Geography (TTM*)
Table 8: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 9: Gilead Sciences, Inc.: M&A Average Deal Size - Value (US$m)
Table 10: Gilead Sciences, Inc.: Targets and Partners
Table 11: Gilead Sciences, Inc.: Top Deals 2018 - 2022YTD*
Table 12: Gilead Sciences, Inc.: Legal Advisor Ranking by Value (US$m)
Table 13: Gilead Sciences, Inc.: Financial Advisor Ranking by Value (US$m)
Table 14: Gilead Sciences, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Table 15: Gilead Sciences, Inc.: M&A Activity by Geography (2018 - YTD*2022)
Table 16: Gilead Sciences, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Table 17: Gilead Sciences, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
Table 18: Gilead Sciences, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Table 19: Gilead Sciences, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Table 20: Gilead Sciences, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 21: Gilead Sciences, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 22: Gilead Sciences, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
Table 23: Gilead Sciences, Inc.: News and Events Summary
Table 24: Gilead Sciences, Inc.: Corporate Governance
Table 25: Gilead Sciences, Inc.: Financial Deals
Table 26: Gilead Sciences, Inc.: Financial Performance
Table 27: Gilead Sciences, Inc.: Market Developments
Table 28: Gilead Sciences, Inc.: Research & Development
Table 29: Gilead Sciences, Inc.: Strategy and Operations
List Of Figures
Figure 1: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Gilead Sciences, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 4: Gilead Sciences, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Gilead Sciences, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Figure 6: Gilead Sciences, Inc.: M&A Activity by Geography (2018 - YTD*2022)
Figure 7: Gilead Sciences, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Figure 8: Gilead Sciences, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
Figure 9: Gilead Sciences, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Figure 10: Gilead Sciences, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Figure 11: Gilead Sciences, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Figure 12: Gilead Sciences, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
Figure 13: Gilead Sciences, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
Related Report
